SCHEMBL31080439

SCHEMBL31080439

CC(C)(C)OC(=O)N1[C@@H]2CCC[C@H]1CC(O)C2

nearest known ligand 0.87

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.87
CHRM1 P11229 1/20 0.87
CHRM3 P20309 1/20 0.87
PREP P48147 4/20 0.50
KAT2B Q92831 1/20 0.42
HSD11B1 P28845 1/20 0.40
HPGD P15428 1/20 0.40
EIF2AK4 Q9P2K8 1/20 0.38
EPHX1 P07099 1/20 0.38
NR1H2 P55055 1/20 0.37
GPR119 Q8TDV5 2/20 0.37
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BTK Q06187 1/20 0.36
LMNA P02545 1/20 0.35
CYP2C9 P11712 1/20 0.35
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL910608 1.00 CHRM2 (0.87) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL910610 1.00 CHRM2 (0.87) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL910981 1.00 CHRM2 (0.87) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL219188 0.93 CHRM2 (1.00) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL22433392 0.93 CHRM2 (1.00) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL19082743 0.93 CHRM2 (1.00) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL641026 0.93 CHRM2 (1.00) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL20636193 0.93 CHRM2 (1.00) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL10106331 0.93 CHRM2 (1.00) CHRM2CHRM1CHRM3PREPKAT2B
SCHEMBL1023170 0.93 CHRM2 (1.00) CHRM2CHRM1CHRM3PREPKAT2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695238-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2026-02-18 EP disclosed
WO-2025077825-A1 METHODS AND COMPOSITIONS FOR TREATING CARDIO-PULMONARY DISORDERS FAUNA BIO INCORPORATED (US) 2025-04-17 WO disclosed
WO-2024216154-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2024-10-17 WO disclosed
WO-2024182747-A2 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2024-09-06 WO disclosed